Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine in Chronic Immune Thrombocytopenia
NCT03229746Phase 4Completed
- Sponsor
- Assiut University
- Start
- Aug 2017
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxychloroquine in immune thrombocytopenia (ITP), sponsored by Assiut University. Started Aug 2017; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT03229746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03229746.